The American Vision Partners-affiliated practice said April 12 that Dr. Perkins participated in the FDA clinical trials for the implant. The lens, which is produced by Staar Surgical, is used to treat nearsightedness and astigmatism.
“Over one million EVO lenses have already been implanted by doctors outside the U.S., and 99.4 percent of EVO patients in a survey have stated they would have the procedure again,” Staar Surgical President and CEO Caren Mason said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.